Heather Turner

Heather Turner oversees Carmot’s operations and governance. Ms. Turner leads the G&A functions as well as portfolio management. Prior to Carmot, Ms. Turner served as Chief General Counsel and Secretary at Lyell Immunopharma, Inc. serving as a member of the executive team and overseeing the legal organization. During her tenure, she led and oversaw the finance, investor relations and alliance management functions. Notably, she oversaw the execution of the company’s $400 million Series C financing, the IPO readiness process as well as the execution of the company’s fourth largest Nasdaq IPO which raised gross proceeds of approximately $425 million. In addition, Ms. Turner significantly engaged in numerous strategic partnerships including the Company’s development and commercialization partnership with GSK which included a $200 million investment. Prior to Lyell, Ms. Turner served as Executive Vice President, General Counsel and Secretary of Sangamo Therapeutics, Inc. a publicly traded gene therapy and gene editing company, where she oversaw the legal and human resources organizations and led the company’s acquisition and integration of a publicly traded French company as well as its expansion into Europe. Prior to Sangamo, Ms. Turner served as Executive Vice President, General Counsel and Head of Portfolio Strategy at Atara Biotherapeutics, Inc., a publicly-traded allogeneic cell therapy company. At Atara, in addition to legal and portfolio strategy, Ms. Turner oversaw human resources as well as medical affairs. She also led secondary financings as well as international tax planning and implementation. Prior to Atara, Ms. Turner served as General Counsel and Secretary at Orexigen Therapeutics, Inc. a publicly-traded company focused on metabolic diseases. During her tenure at Orexigen, Ms. Turner oversaw the legal, human resources, government affairs and facilities functions. Ms. Turner was also actively involved in engagements with FDA and EMA related to their approvals of Orexigen’s obesity drug. Ms. Turner started her career at Cooley as a corporate securities associate. Ms. Turner received her J.D. from UCLA School of Law and her B.A. in Environmental Studies from the University of California, Santa Barbara.